{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:14:57Z","timestamp":1775060097305,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":862,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1038\/s41379-020-0543-y","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T04:04:13Z","timestamp":1587355453000},"page":"1802-1810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7290-4004","authenticated-orcid":false,"given":"Emily","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karuna","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley A.","family":"Stohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-020-0543-y_bib1","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/PAS.0b013e31802f5d33","article-title":"Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma","volume":"31","author":"Chuang","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0543-y_bib2","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1097\/PAS.0000000000000238","article-title":"Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference","volume":"38","author":"Epstein","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0543-y_bib3","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1097\/PAS.0b013e318260cde7","article-title":"Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung","volume":"36","author":"Chang","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0543-y_bib4","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/PAS.0000000000000240","article-title":"Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference","volume":"38","author":"Amin","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0543-y_bib5","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/PAS.0000000000000178","article-title":"Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall","volume":"38","author":"Gordetsky","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0543-y_bib6","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00000478-200405000-00014","article-title":"Prostate carcinoma with squamous differentiation: an analysis of 33 cases","volume":"28","author":"Parwani","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0543-y_bib7","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/modpathol.2011.7","article-title":"ERG gene rearrangements are common in prostatic small cell carcinomas","volume":"24","author":"Lotan","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-0543-y_bib8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/PAS.0b013e318157020e","article-title":"Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases","volume":"32","author":"Osunkoya","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0543-y_bib9","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1158\/1078-0432.CCR-13-3309","article-title":"Aggressive variants of castration-resistant prostate cancer","volume":"20","author":"Beltran","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-0543-y_bib10","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1002\/1097-0142(19930601)71:11<3783::AID-CNCR2820711149>3.0.CO;2-X","article-title":"Dedifferentiation of locally recurrent prostate cancer after radiation therapy. Evidence for tumor progression","volume":"71","author":"Wheeler","year":"1993","journal-title":"Cancer"},{"key":"10.1038\/s41379-020-0543-y_bib11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0046-8177(92)90080-M","article-title":"Histologic changes of irradiated prostatic carcinoma diagnosed by transrectal ultrasound","volume":"23","author":"Siders","year":"1992","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-020-0543-y_bib12","doi-asserted-by":"crossref","unstructured":"Mazzone E, Mistretta FA, Knipper S, Palumbo C, Tian Z, Pecoraro A, et al. Long-term incidence of secondary bladder and rectal cancer in patients treated with brachytherapy for localized prostate cancer: a large-scale population-based analysis. BJU Int. 2019. https:\/\/doi.org\/10.1111\/bju.14841.","DOI":"10.1111\/bju.14841"},{"key":"10.1038\/s41379-020-0543-y_bib13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.eururo.2018.09.034","article-title":"External beam radiotherapy increases the risk of bladder cancer when compared with radical prostatectomy in patients affected by prostate cancer: a population-based analysis","volume":"75","author":"Moschini","year":"2019","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-020-0543-y_bib14","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"The molecular taxonomy of primary prostate cancer","volume":"163","author":"Cancer Genome Atlas Research Network.","year":"2015","journal-title":"Cell"},{"key":"10.1038\/s41379-020-0543-y_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","author":"Cancer Genome Atlas Research Network.","year":"2014","journal-title":"Nature"},{"key":"10.1038\/s41379-020-0543-y_bib16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"key":"10.1038\/s41379-020-0543-y_bib17","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1038\/s41379-020-0543-y_bib18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Disco"},{"key":"10.1038\/s41379-020-0543-y_bib19","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1073\/pnas.1303607110","article-title":"TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal","volume":"110","author":"Killela","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/s41379-020-0543-y_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000381903","article-title":"Frequency of TERT promoter mutations in prostate cancer","volume":"82","author":"Stoehr","year":"2015","journal-title":"Pathobiology"},{"key":"10.1038\/s41379-020-0543-y_bib21","doi-asserted-by":"crossref","unstructured":"Lara PN, Heilmann AM, Elvin JA, Parikh M, de Vere White R, Gandour-Edwards R, et al. TMPRSS2-ERG fusions unexpectedly identified in men initially diagnosed with nonprostatic malignancies. JCO Precis Oncol. 2017;2017. https:\/\/doi.org\/10.1200\/PO.17.00065.","DOI":"10.1200\/PO.17.00065"},{"key":"10.1038\/s41379-020-0543-y_bib22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/PAI.0000000000000588","article-title":"High-grade adenocarcinoma of the prostate mimicking urothelial carcinoma is negative for TERT mutations","volume":"27","author":"Alaghehbandan","year":"2019","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/s41379-020-0543-y_bib23","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/modpathol.2011.56","article-title":"ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin","volume":"24","author":"Williamson","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-0543-y_bib24","doi-asserted-by":"crossref","unstructured":"Mannan R, Taylor AS, Spratt DE, Chinnaiyan AM, Montgomery JS, Brown NA, et al. TERT- beyond the territory: Usage of PCR-based TERT promoter assay in defining urothelial carcinoma in a case of long-standing prostatic adenocarcinoma. Pathol Res Pract. 2019;152663.","DOI":"10.1016\/j.prp.2019.152663"},{"key":"10.1038\/s41379-020-0543-y_bib25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/path.5243","article-title":"Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma","volume":"248","author":"Joseph","year":"2019","journal-title":"J Pathol"},{"key":"10.1038\/s41379-020-0543-y_bib26","doi-asserted-by":"crossref","first-page":"i333","DOI":"10.1093\/bioinformatics\/bts378","article-title":"DELLY: structural variant discovery by integrated paired-end and split-read analysis","volume":"28","author":"Rausch","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1038\/s41379-020-0543-y_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms5988","article-title":"Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer","volume":"5","author":"Pritchard","year":"2014","journal-title":"Nat Commun"},{"key":"10.1038\/s41379-020-0543-y_bib28","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/jclinpath-2013-201586","article-title":"Diagnostic utility of androgen receptor expression in discriminating poorly differentiated urothelial and prostate carcinoma","volume":"66","author":"Downes","year":"2013","journal-title":"J Clin Pathol"},{"key":"10.1038\/s41379-020-0543-y_bib29","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/modpathol.2014.115","article-title":"Prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas","volume":"28","author":"Tan","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-0543-y_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0543-y_bib31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1309\/AJCPK1OV6IMNPFGL","article-title":"Evaluation of contemporary prostate and urothelial lineage biomarkers in a consecutive cohort of poorly differentiated bladder neck carcinomas","volume":"142","author":"Mohanty","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/s41379-020-0543-y_bib32","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/PAS.0b013e3181e6cbf3","article-title":"NKX3.1 as a marker of prostatic origin in metastatic tumors","volume":"34","author":"Gurel","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0543-y_bib33","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.urolonc.2019.03.008","article-title":"Combination of androgen receptor inhibitor and cisplatin, an effective treatment strategy for urothelial carcinoma of the bladder","volume":"37","author":"Tyagi","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1038\/s41379-020-0543-y_bib34","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1016\/j.clgc.2017.09.016","article-title":"Association of androgen receptor expression on tumor cells and PD-L1 expression in muscle-invasive and metastatic urothelial carcinoma: insights for clinical research","volume":"16","author":"Necchi","year":"2018","journal-title":"Clin Genitourin Cancer"},{"key":"10.1038\/s41379-020-0543-y_bib35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/PAP.0b013e3182862ac5","article-title":"Clinical applications of novel ERG immunohistochemistry in prostate cancer diagnosis and management","volume":"20","author":"Shah","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"10.1038\/s41379-020-0543-y_bib36","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/pros.22836","article-title":"Frequent discordance between ERG gene rearrangement and ERG protein expression in a rapid autopsy cohort of patients with lethal, metastatic, castration-resistant prostate cancer","volume":"74","author":"Udager","year":"2014","journal-title":"Prostate"},{"key":"10.1038\/s41379-020-0543-y_bib37","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00428-013-1495-0","article-title":"HOXB13 is a sensitive and specific marker of prostate cells, useful in distinguishing between carcinomas of prostatic and urothelial origin","volume":"463","author":"Varinot","year":"2013","journal-title":"Virchows Arch"},{"key":"10.1038\/s41379-020-0543-y_bib38","doi-asserted-by":"crossref","first-page":"5085373","DOI":"10.1155\/2019\/5085373","article-title":"Molecular composition of genomic TMPRSS2-ERG rearrangements in prostate cancer","volume":"2019","author":"Krumbholz","year":"2019","journal-title":"Dis Markers"},{"key":"10.1038\/s41379-020-0543-y_bib39","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/modpathol.2009.193","article-title":"Prevalence of TMPRSS2\u2013ERG and SLC45A3\u2013ERG gene fusions in a large prostatectomy cohort","volume":"23","author":"Esgueva","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-0543-y_bib40","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamaoncol.2018.5801","article-title":"Analysis of the prevalence of microsatellite instability in prostate cancer and response to immune checkpoint blockade","volume":"5","author":"Abida","year":"2019","journal-title":"JAMA Oncol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0543-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0543-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222007098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222007098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0543-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:41:00Z","timestamp":1760229660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222007098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0893395222007098"],"URL":"https:\/\/doi.org\/10.1038\/s41379-020-0543-y","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-020-0543-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}